Jupiter Neurosciences Stockholders Approve Reverse Split
Jupiter Neurosciences, Inc. held its 2026 Annual Meeting of Stockholders on July 22, 2026, where a quorum was present with approximately 59% of outstanding shares represented. Stockholders approved a reverse stock split at a ratio between 1:10 and 1:100, and an amendment to the 2025 Equity Incentive Plan to increase available shares by 5,250,000. Additionally, seven director nominees were elected, Cherry Bekaert LLC was ratified as the independent auditor, and Dr. Andrew J. Cutler was appointed to the Compensation Committee. The company also provided an update on its Standby Equity Purchase Agreement, confirming receipt of $5.58 million in prepaid advances from Yorkville, in exchange for $6.0 million in convertible notes.
Key Highlights
- Stockholders approved a reverse stock split at a ratio of 1:10 to 1:100.
- 2025 Equity Incentive Plan amended to increase shares by 5,250,000.
- Seven director nominees were elected, including Dr. Andrew J. Cutler.
- Dr. Andrew J. Cutler was appointed to the Compensation Committee.
- Cherry Bekaert LLC was ratified as the independent auditor for 2026.
- Company received $3.72 million and $1.86 million in prepaid advances from Yorkville.
- Issued $4.0 million and $2.0 million convertible notes with 7.0% original issue discount.
- Convertible notes have an initial conversion price of $1.50 per share.
Price Impact
More from JUNS